540 results on '"Rosenfeld RG"'
Search Results
2. HeterozygousSTAT5bGene Mutations: Impact on Clinical Phenotype.
3. A Novel Y332C Missense Mutation in the Intracellular Domain of the Human Growth Hormone Receptor (GHR) Does Not Alter STAT5b Signaling: Redundancy of GHR Intracellular Tyrosines Involved in STAT5b Signaling.
4. Severe Short Stature Caused by Novel Compound Heterozygous Mutations of the Insulin-Like Growth Factor 1 Receptor.
5. A Case of Severe IGF-1 Deficiency Secondary to a Novel Homozygous Deletion in the Growth Hormone Receptor (GHR) Gene.
6. A Novel Heterozygous STAT5b Variant, N160S, Associated with Modest Short Stature.
7. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society (Reprinted from J Clin Endocrinol Metab, vol 85, pg 3990-3993, 2000)
8. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society
9. Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop held in Pisa, Italy, 27-28 March 1998
10. Novel spinal dysplasia in two generations
11. SERUM PTROTEOLYSIS OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN (IGFBP)-3, IGFBP-4, AND IGFBP-5 IN PATIENTS UNDERGOING ABDOMINAL SURGERY
12. New molecular mechanisms of GH resistance
13. Effects of sodium butyrate on expression of members of the IGF-binding protein superfamily in human mammary epithelial cells
14. Natural history of growth hormone receptor deficiency
15. Growth hormone insensitivity: our current understanding and future directions
16. Serum levels of insulin-like growth factor binding proteins in Ecuadorean children with growth hormone insensitivity
17. Insulin-like growth factor binding proteins: a proposed superfamily
18. Treatment of growth hormone insensitivity syndrome with insulin-like growth factor I: long-term results of the European multicentre study
19. Gender-specific dose-responses to GH in GHD children: Results of a 3-year randomized trial in 109 patients
20. An endocrinologist's approach to the growth hormone-insulin-like growth factor axis
21. Intrauterine growth retardation: our current understanding and future directions
22. Growth hormone insensitivity syndromes
23. Body changes in adolescent patients with growth hormone receptor deficiency receiving recombinant human insulin-like growth factor I and luteinizing hormone-releasing hormone analogue: preliminary results
24. Insulin‐like growth factor binding proteins and their regulation
25. Effects of insulin‐like growth factor I treatment on the molecular distribution of insulin‐like growth factors among different binding proteins
26. Heart rate increases in patients with growth hormone receptor deficiency treated with insulin‐like growth factor I
27. Is there heterozygote expression of growth hormone receptor deficiency?
28. Pharmacokinetics of recombinant human insulin‐like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency
29. Serum profiles of insulin‐like growth factors and their binding proteins in adults with growth hormone receptor deficiency treated with insulin like growth factor I
30. Insulin Resistance Is Associated With Increased Serum Concentration of IGF-Binding Protein-Related Protein 1 (IGFBP-rP1/MAC25)
31. The use -- and misuse -- of growth hormone.
32. Insulin-like growth factors and the basis of growth.
33. Growth hormone insensitivity associated with a STAT5b mutation.
34. What Is the Role for Pediatric Endocrinologists in the Management of Skeletal Dysplasias?
35. A Novel, Heterozygous, de novo Splicing Variant Affecting the Intracellular Domain of the Growth Hormone Receptor, and Causing a Mild Short Stature.
36. The History of the Insulin-Like Growth Factor System.
37. Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study.
38. Pregnancy-Associated Plasma Protein (PAPP)-A2 in Physiology and Disease.
39. Genetic causes of growth hormone insensitivity beyond GHR.
40. When Is a Positive Test for Pediatric Growth Hormone Deficiency a True-Positive Test?
41. A Novel Mutation in Insulin-Like Growth Factor 1 Receptor (c.641-2A>G) Is Associated with Impaired Growth, Hypoglycemia, and Modified Immune Phenotypes.
42. Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action.
43. Growth and growth hormone in Turner syndrome: Looking back, looking ahead.
44. Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program.
45. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.
46. Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective.
47. Screening a large pediatric cohort with GH deficiency for mutations in genes regulating pituitary development and GH secretion: Frequencies, phenotypes and growth outcomes.
48. Monitoring rhGH Safety: rhGH Registries, SAGhE and Future Needs.
49. Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation.
50. Mortality in Children Receiving Growth Hormone Treatment of Growth Disorders: Data From the Genetics and Neuroendocrinology of Short Stature International Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.